Table 3.
Antibody | Case 1 | Case 2 | Case 3 |
Case 4 |
|
Primary | Recurrent | ||||
Age (yr)/sex | 63/M | 39/M | 56/M | 43/F | 44/F |
Vimentin | + | + | + | + | + |
α-1-antitrypsin | + | + | + | + | + |
Cytokeratin 18 | +F | +F | - | +F | +F |
Cytokeratin 19 | +F | +F | - | +F | +F |
CD68 | + | + | + | + | + |
CD56 | + | + | + | + | + |
Desmin | - | +F | +F | - | +F |
α-SMA | - | - | - | - | +F |
Myoglobin | - | - | - | - | +F |
CD117 | - | - | - | - | - |
S-100 | - | - | - | - | +F |
CD34 | - | - | - | - | +F |
HMB45 | - | - | - | - | - |
Hep Par 1 | - | - | - | - | - |
AFP | - | - | - | - | - |
HBsAg | - | - | - | - | - |
p53 | - | - | + | + | + |
pCEA | - | - | - | - | - |
mCEA | - | - | - | - | - |
EMA | - | - | - | - | - |
NSE | - | - | - | - | - |
Chromogranin A | - | - | - | - | - |
Synaptophysin | - | - | - | - | - |
Ki67 | 60% | 50% | 45% | 40% | 65% |
+F: Focal staining; AFP: α-fetoprotein; SMA: Smooth muscle actin; HBsAg: Hepatitis B virus surface antigen; EMA: Epithelial membrane antigen; NSE: Neuron specific enolase; pCEA: Polyclonal carcinoembryonic antigen; mCEA: Monoclonal carcinoembryonic antigen.